PRESS RELEASE Solvay Press Releases Gadgets · Jul 29, 2026

Solvay second quarter 2026 results

In brief · 4 sentences
Based on Solvay Press Releases · Jul 29, 2026

Solvay reported lower Q2 2026 earnings due to a Middle East plant shutdown and weaker volumes, but confirmed full-year guidance and plans to restart the facility in Q3.

Solvay second quarter 2026 results
Solvay Press Releases — Solvay
Key points
·
Main topic: second quarter 2026 results.
·
Category affected: gadgets and hardware.
·
Figures mentioned: 2026, 770 million, 850 million.
·
The information comes from a press release or official channel.
·
The next step is to watch availability, pricing and real-world impact.

The useful question is what changes for users, developers or buyers, and whether the announcement stays industry context or becomes something people can actually use.

Solvay’s second quarter 2026 results showed a decline in underlying net sales to €1,031 million, down 6.4% year-on-year, primarily due to lower volumes in Peroxides and Special Chem. The temporary shutdown of the Peroxides plant in Jubail, Saudi Arabia, following regional conflict, reduced output by approximately €20 million in EBITDA. Despite these challenges, the company maintained stable pricing across most businesses, with soda ash seaborne markets experiencing slight declines.

Underlying EBITDA for the quarter fell 18.8% to €187 million, with the Middle East conflict accounting for roughly half of the decline. Fixed costs contributed positively through operational savings, offsetting inflation. Free cash flow to shareholders was negative €11 million in Q2, impacted by capital expenditures and working capital changes, though H1 2026 saw a positive €15 million. The company’s net financial debt rose to €1.8 billion, driven by dividend payments.

Solvay reaffirmed its full-year 2026 guidance, targeting underlying EBITDA between €770 million and €850 million, despite a €20 million negative currency impact and €40 million in transformation expenses. Free cash flow from continuing operations is expected to reach at least €200 million, with capital expenditures around €300 million. The company also aims for cumulative structural cost savings of €300 million by year-end, maintaining strong cash discipline as a priority.

The company announced strategic investments of €15-20 million to expand rare earth separation capacities at its La Rochelle facility in France, supported by new customer commitments. A Letter of Intent with Viridis secures rare earth supply from Brazil, reinforcing Solvay’s position in Europe’s rare earth separation market. Industrial-scale separation of dysprosium and terbium is set to begin in autumn 2026, further strengthening its capabilities in critical rare earth elements.

Original source → Deals on Clipraptor.com →
Extracted signals · detected in the story
OurMiddle EastMarchPeroxidesDespiteMaintainingFollowingAnticipatingSaudi ArabiaUnderlying EBITDA2026770 million850 million20 million1.20